DARA BioSciences, Inc. Launches Oral Mucositis Care App To Provide Cancer Patients With An Educational Resource To Improve Side Effect Management

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced the launch of a smartphone app to provide cancer patients an educational resource to help improve oral care and management of oral mucositis. This is being accompanied by the release of a list of “Top 10 Oral Care Tips” < http://gelclair.com/top-10-oral-hygiene-tips > for Cancer Patients.

Help employers find you! Check out all the jobs and post your resume.